Butanediamide,N1-(32-amino-7,16,25-trioxo-6,10,15,19,24,28-hexaazadotriacont-1-yl)-2-[[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-,(2S)- (9CI) (119613-51-3)

Identification
Name:	Butanediamide,N1-(32-amino-7,16,25-trioxo-6,10,15,19,24,28-hexaazadotriacont-1-yl)-2-[[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-,(2S)- (9CI)
Synonyms:	Butanediamide,N1-(32-amino-7,16,25-trioxo-6,10,15,19,24,28-hexaazadotriacont-1-yl)-2-[[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-,(S)-; NPTX 5; Nephilatoxin 5
CAS:	119613-51-3
Molecular Formula:	C40H69 N11 O7
Molecular Structure:
Properties
Safety Data

Other Product

L-Aspartamide,N2-[(4-hydroxy-1H-indol-3-yl)acetyl]-L-ornithyl-N1-(32-amino-7,16,25-trioxo-6,10,15,19,24,28-hexaazadotriacont-1-yl)-(9CI)
Butanediamide,N1-(31-amino-7,15,24-trioxo- 6,9,14,18,23,27-hexaazahentriacont-1-yl)-2- [[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-,(2S)-
Butanediamide,N1-(31-amino-7,15,24-trioxo-6,10,14,18,23,27-hexaazahentriacont-1-yl)-2-[[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-,(2S)- (9CI)
Butanediamide,N1-[(16S)-16,21-diamino-21-imino-15-oxo-6,10,14,20-tetraazaheneicos-1-yl]-2-[[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-,(2S)- (9CI)
Butanediamide,2-[[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-N1-(8,19,24-triamino-24-imino-13-methyl-7,18-dioxo-6,13,17,23-tetraazatetracos-1-yl)-(9CI)
Butanediamide,N1-(16,21-diamino-21-imino-15-oxo-6,10,14,20-tetraazaheneicos-1-yl)-2-[[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-(9CI)
Butanediamide,N1-[5-[[3-[[4-[(3-aminopropyl)amino]butyl]amino]-1-oxopropyl]amino]pentyl]-2-[[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-,(2S)- (9CI)
Butanediamide,N1-(41-amino-7,16,25,34-tetraoxo-6,10,15,19,24,28,33,37-octaazahentetracont-1-yl)-2-[[(4-hydroxy-1H-indol-3-yl)acetyl]amino]-,(2S)- (9CI)
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
Butanediamide,N1-[5-[[3-[(3-aminopropyl)- amino]-1-oxopropyl]amino]pentyl]-2-[[(4- hydroxy-1H-indol-3-yl)acetyl]amino]-,(2S)-
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
Butanediamide,2-[(1H-indol-3-ylacetyl)amino]-N1-(8,19,24-triamino-24-imino-13-methyl-7,18-dioxo-6,13,17,23-tetraazatetracos-1-yl)-(9CI)
Butanediamide,N1-[5-[[3-[(4-aminobutyl)amino]-1-oxopropyl]amino]pentyl]-2-[(1H-indol-3-ylacetyl)amino]-,(2S)- (9CI)
Butanediamide,N1-[(16S)-16,21-diamino-21-imino-15-oxo-6,10,14,20-tetraazaheneicos-1-yl]-2-[[2-(2,4-dihydroxyphenyl)acetyl]amino]-,(2S)-
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H